Research shows sick leave among patients prescribed GLP-1 injections over nine-month period reduced by 50%Weight-loss drugs could halve sickness absence and significantly reduce the strain on the NHS, research suggests.A UK study of patients who received GLP-1 jabs for nine months found sickness days fell by nearly half and sickness absence lasting five days or more fell by more than 50%. Analysis of the findings suggests expanding access could cut A&E attendance by obese patients by a quarter and free up nearly 10m GP appointments. Continue reading...

Source: https://www.theguardian.com/science/2026/may/14/weight-loss-jabs-sick-leave-wegovy-health